首页> 美国卫生研究院文献>Taylor Francis Open Select >Biomarkers and brains: situating dementia in the laboratory and in the memory clinic
【2h】

Biomarkers and brains: situating dementia in the laboratory and in the memory clinic

机译:生物标志物和大脑:将痴呆症置于实验室和记忆诊所中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper provides a comparison of how genetic biomarkers are used (or not) in three contexts: clinic-based diagnostic work with people; lab-based research on mice and their marbles; and lab-based research on thrashing nematodes. For all the worldwide drive to find biomarkers that can be used in the detection of early, presymptomatic dementia, there is little research on how or when the association between biomarkers and a definitive disease are being made to “hold.” First, we show the disjuncture between the animal modeling that underpins laboratory attempts to stabilize genetic biomarkers and the paradigms that inform clinical diagnosis. Secondly, we develop this theme to show how in our third site, an epigenetics “worm” laboratory, neurodegenerative changes are explored as located in specific gene-environment interactions over time. We speculate whether such an enactment brings us closer to a notion of “situated biology,” to undercut possibilities of making genetic biomarkers of preclinical dementia hold.
机译:本文比较了在以下三种情况下如何使用(或不使用)遗传生物标志物:基于临床的人间诊断工作;基于实验室的小鼠及其大理石研究;以及基于实验室的对rash线虫的研究。对于全球范围内寻找可用于早期症状前痴呆检测的生物标志物的所有驱动力,几乎没有关于如何或何时使生物标志物与确定性疾病之间的联系“保持”的研究。首先,我们展示了支持稳定遗传生物标记物的实验室尝试的动物模型与告知临床诊断的范例之间的脱节。其次,我们开发此主题以显示在我们的第三个站点中,如何在表观遗传学“蠕虫”实验室中探索神经退行性变化,因为它们随着时间的推移位于特定的基因-环境相互作用中。我们推测这样的制定是否使我们更接近“处境生物学”的概念,从而削弱了使临床前痴呆症的遗传生物标记物成立的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号